After more than two decades of being primarily known for exclusively selling one product, portable oxygen containers, Goleta-based Inogen has spent the last couple of years branching out. That is ...

Yuwell, through its whole-owned subsidiary Yuwell (Hong Kong) Holdings, has agreed to invest approximately $27.2m in Inogen, ...

Inogen, Inc. INGN recently announced a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

Needham analyst Michael Matson has maintained their neutral stance on INGN stock, giving a Hold rating on January 14.Invest with Confidence: ...

Inogen (NASDAQ:INGN – Get Free Report)‘s stock had its “hold” rating reaffirmed by investment analysts at Needham & Company LLC in a report issued on Thursday,Benzinga reports. Separately, ...

On the eve of theArab Health Exhibition Yuwell Medical held its 2025 Global Core Partner Conference in Dubai and announced a ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid second-quarter 2024 ...

This raises our optimism about the stock. In October 2024, Inogen commenced the U.S. market release of the Rove 4 Portable Oxygen Concentrator (POC). This is likely to have witnessed a robust product ...

More on INGN’s Robust Product Portfolio Inogen’s expanding product portfolio is a significant driver of its growth. It offers a range of oxygen concentrator solutions for both portable and ...

On the eve of the Arab Health Exhibition, Yuwell Medical held its 2025 Global Core Partner Conference in Dubai, and announced ...